Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Swiss healthcare market
Proven track record of resilient and stable growth
Development of Swiss healthcare retail sector¹
in billion CHF (based on ex-manufacturer price)
2011-21 CAGR 2.6%²
2022-25 CAGR 2.0%³
5
4.9
5.0
5.1
4
4.2
4.4
4.4
4.5
4.6
4.1
3.8
3.9
3.9
3.9
3
2
1
IIII
5.2
5.3
0
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022E
2023E
2024E
2025E
-
Underlying healthcare sector growth drivers, including demographics,
lifestyle and innovation
One of the highest life expectancy rates in the world
Non-discretionary nature of products and services
Source: IQVIA, Pharmaceutical Market Switzerland, YTD December 2021, Medicines Swissmedic lists A, B, D, sold from suppliers and wholesalers to physicians and drugstores
Total market without hospitals
1
2
3
IQVIA, Pharmaceutical Market Switzerland, YTD December 2021
Company estimate
08/08/22
Mandatory price cuts
29
GALENICAView entire presentation